tirzepatide benefits and side effects for Weight Loss Tirzepatide vs. Semaglutide: Which Weight

Adults with overweight or obesity taking the once-weekly GIP/GLP-1 receptor agonist tirzepatide achieved a mean weight loss of at least 16% at 72 weeks, according to topline results from the SURMOUNT-1 clinical trial

At Genesis Lifestyle Medicine, we are committed to helping you explore all your options for improved heart and overall health

1,0 mL = 10 mg

Investigators found GLP-1s are effective in helping kids and teens manage weight and diabetes, with no increase in serious mental health risks compared with placebo.

A retatrutida uma molcula ainda em fase de estudos para o tratamento da obesidade e de distrbios metablicos

Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.